Active Cancer Biomarkers Grants

PI Name Organization - Companysort ascending Title Major Program / Research Group FOA
Mallick, Parag Kumar Stanford University Pathomic Predictors of Prostate Cancer Progression Consortium for Imaging and Biomarkers PAR-19-264: Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer
Pitteri, Sharon Stanford University Glycosylation and Immune Evasion in Urologic Tumors Alliance of Glycobiologists for Cancer Research PAR-17-206: Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories
Bertozzi, Carolyn Stanford University Chemical Glycoproteomics PA-20-185: NIH Research Project Grant
Lundberg, Emma Stanford University PROMINENT - Stanford
Tempst, Paul Sloan-Kettering Inst Can Research Protein and proteolytic activity biomarkers of early stage pancreatic cancer PA-16-160: NIH Research Project Grant
Kingham, T Peter Sloan-Kettering Inst Can Research Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries RFA-CA-15-024: Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UG3/UH3)
Wei, Lei Roswell Park Cancer Institute Corp Advancing skin cancer prevention by tackling UV-induced clonogenic mutations PA-19-056: Research Project Grant
Linnes, Jacqueline Purdue University Point-of-care screening test for early cervical cancer detection PAR-19-158: Bioengineering Research Grants (BRG)
Nappi, Lucia Provincial Health Services Authority Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration. Consortium for Imaging and Biomarkers PAR-19-264: Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer
Nautiyal, Shivani Prime Genomics, Inc. Device for Preservation of Cell Free RNA in Saliva RFA-CA-20-019: Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research
Ibsen, Stuart D. Oregon Health & Science University Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers PAR-20-053: Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection
Heinrich, Michael C Oregon Health & Science University Novel models for functional profiling of germline SDH variants associated with cancer PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Ibsen, Stuart D. Oregon Health & Science University Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers PAR-20-053: Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection
Faris, Gregory W Numentus Technologies Inc. Decoding Individual Exosomes in Cancer RFA-CA-20-017: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Ivanov, Alexander R. Northeastern University Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

Pages